Baxter International (BAX) Q2 Earnings: What's In Store?
Zacks Investment Research | Jul 20, 2016 09:29PM ET
Baxter International Inc. (NYSE:BAX) is scheduled to report second-quarter 2016 earnings on Jul 26. Last quarter, Baxter reported earnings of 36 cents per share, which beat the Zacks Consensus Estimate of 7 cents by 24.1%.
Notably, the company’s earnings have topped the Zacks Consensus Estimate in the last four quarters, by an average of 27.65%.
Let’s see how things are shaping up prior to this quarter.
Factors at Play
For the second quarter of 2016, Baxter expects sales growth of 4% at cc. Adjusted earnings are forecasted in the range of $0.38 to $0.40 per share.
We believe that Baxter’s expanding product pipeline is a key growth catalyst. Newly launched products like SIGMA SPECTRUM infusion pump and AMIA APD cycler with SHARESOURCE two-way connectivity are expected to drive top-line growth in the quarter.
The Renal business is predicted to be a pivotal growth driver. Baxter is focused on expanding its end-stage renal disease (ESRD) product portfolio. Aging population, expanding access in emerging markets and growing adoption of home therapies are the main catalysts.
BAXTER INTL Price and EPS Surprise/h3
Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.